About Us

Moosun Group

For a Healthier Animal World

Moosun Group, founded in 1995, is a comprehensive high-tech enterprise specializing in the R&D, production, marketing and technical services of veterinary drugs, feed additives and poultry vaccines. With more than 600 employees and a registered capital of USD 38 million, the company operates 18 production lines, covering powder, premix, feed additives, oral solutions, disinfectants, insecticides, granules, injections and vaccines.

VIEW MORE
1995 year

Company Establishment

600 +

Current Employees

38 million

Registered Capital (USD)

18 Articles

Production Line

Products

Our core business encompasses veterinary drugs, feed additives, and poultry vaccines

Vaccine Veterinary drugs Feed Additives Disinfectant

Vaccine

Moosun Group is a comprehensive high-tech enterprise specializing in R&D, production, marketing and technical service for veterinary drug, feed additive and poultry vaccine.

Veterinary drugs

Moosun Group is a comprehensive high-tech enterprise specializing in R&D, production, marketing and technical service for veterinary drug, feed additive and poultry vaccine.

Feed Additives

Moosun Group is a comprehensive high-tech enterprise specializing in R&D, production, marketing and technical service for veterinary drug, feed additive and poultry vaccine.

Disinfectant

Moosun Group is a comprehensive high-tech enterprise specializing in R&D, production, marketing and technical service for veterinary drug, feed additive and poultry vaccine.

Quality and R&D

Our core business encompasses veterinary drugs, feed additives, and poultry vaccines

R&D Idea

The company has built comprehensive R&D and talent development platforms, including a National Enterprise Technology Center, a Postdoctoral Research Station, and an Academician Workstation.

01

Achievements

Moosun Group has obtained 13 National New Veterinary Drug Certificates. The company has accumulated 380 patent applications in China, of which 278 patents have been granted, including 85 invention patents.

02

Research Areas

Based on the company’s strong R&D capabilities, we focus our research on addressing the core challenges faced by global customers.

03

Blog

Our core business encompasses veterinary drugs, feed additives, and poultry vaccines

Qixiang Factory

Qixiang Factory

Dec 09,2025

Indonesia Exhibition Photos

Indonesia Exhibition Photos

Dec 09,2025

Middle East Exhibitions

Middle East Exhibitions

Dec 09,2025

视频标题